Antituberculous Drug Resistance in Western Canada (1993 to 1994)
OBJECTIVES: To estimate the magnitude of antituberculous drug resistance and identify prospectively the risk factors for its development in tuberculosis (TB) patients in western Canada over a one-year period.
Main Authors: | Richard Long, Anne Fanning, Robert Cowie, Vernon Hoeppner, Mark Fitzgerald, The Western Canada Tuberculosis Group |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
1997-01-01
|
Series: | Canadian Respiratory Journal |
Online Access: | http://dx.doi.org/10.1155/1997/169521 |
Similar Items
-
The Lack of Association Between Bacille Calmette-Guerin Vaccination and Clustering of Aboriginals with Tuberculosis in Western Canada
by: Victoria J Cook, et al.
Published: (2005-01-01) -
The structural analysis of government expenditures on the purchase of antituberculous drugs
by: Iuliia Korzh, et al.
Published: (2021-04-01) -
Severe Hepatic Complications of Antituberculous Therapy
by: Mark O Turner, et al.
Published: (1999-01-01) -
Paradoxical response to antituberculous therapy
by: Tamer Ibraheem
Published: (2014-01-01) -
Antimycobacterial Activities of an Edible Mushroom Extract and its Synergy with the Standard Antituberculous Drugs
by: Debasmita Chatterjee, et al.
Published: (2018-06-01)